Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression profiling by high throughput sequencing (RNA sequencing)

ABSTRACT: RNAseq of CLDN6 sorted Epiblast Stem Cells (EpiSCs), WT vs Pbx1-KO lines in mouse embryonic stem cells (ES (2i/LIF and serum/LIF) and EpiSCs, as well as across differentiation (EpiSCs differentiated towards Posterior Primitive Streak (PPS) and Extraembryonic Mesoderm (ExM). Also EpiSCs treated with PD03 (MEK inhibitor) and 6h of WNT stimulation (CHIR).

INSTRUMENT(S): Tissue Culture Lab, Computer, Wet Lab, NextSeq 500

ORGANISM(S): Mus musculus

SUBMITTER: Adrija Kalvisa

PROVIDER: E-MTAB-13618 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

RNA-seq of wild-type and PGR (progesterone receptor) knockout pluripotent mouse EpiSCs (epiblast stem cells) and differentiated samples derived from these cell lines (primitive streak and mesoderm)

Project description:EpiSCs (epiblast stem cells) are murine pluripotent stem cells derived from the epiblast of a post-implantation embryo. These cells are primed to differentiate towards embryonic germ layers and are a useful model to study these early developmental events. PGR (progesterone receptor) is a nuclear receptor described mainly in the context of fertility and breast cancer. We noticed that it is also a TF that is expressed in primed EpiSCs, but not in naive mESCs and is further upregulated during mesoderm specification. We hypothesized that it is involved in differentiation to primitive streak and mesoderm progenitors. To test this hypothesis we generated EpiSCs with a genetic knockout of PGR using CRISPR-Cas9-mediated knock-in of an antibiotic resistance cassette. Differentiation of the wild-type and knockout cells and comparison of the different cell types allowed us to conclude that PGR is important for acquiring extraembryonic mesoderm fate and modulates cardiac differentiation, specifically it ensures that correct pools of FHF (first heart field) and SHF (second heart field) are being produced. Our study sheds light on previously unappreciated role of PGR in early embryonic development.

2022-11-30 | E-MTAB-12104 | biostudies-arrayexpress

RNA-seq of wild-type, Pbx1/Pbx2 double-knockout and pMsgn1-mut EpiSCs differentiated in vitro to pre-somitic mesoderm in the first 24 hours of differentiation.

Project description:In vertebrates, body axis elongation is fuelled by bipotent neuromesodermal progenitors (NMPs), which support the development of both spinal cord and paraxial mesoderm (PM). HOX transcription factors have been historically implicated in axial elongation, with their sequential activation playing a fundamental role in timing PM development. PBX1 and PBX2 are obligate anterior HOX cofactors, and therefore they represent prominent candidates for controlling the distinct response to individual HOX factors. In our work, we have demonstrated that PBX proteins play a fundamental role in promoting the expression of PM genes, including the master regulator Mesogenin1 (Msgn1). To address the role of PBX proteins in PM differentiation, RNA-seq was performed on wild-type (WT) and Pbx1/Pbx2 double-knockout (Pbx1/2-DKO) EpiSCs differentiated in vitro to pre-somitic mesoderm (PSM) at different time-points (12 hours and 24 hours). To establish the direct transcriptional regulation of Msgn1 by PBX/HOX, we employed the CRISPR/Cas9 technology to generate lines carrying base-pair substitutions on the Msgn1 promoter (pMsgn1-mut) that abrogate the recruitment of PBX/HOX complexes, and we performed RNA-seq of pMsgn1-mut EpiSCs differentiated in vitro to PSM at 24 hours. All differentiation experiments were performed in biological triplicates with WT and Pbx1/2-DKO lines, and in biological duplicates with pMsgn1-mut lines.

2021-07-21 | E-MTAB-9773 | biostudies-arrayexpress

scRNA-seq for mEpiSCs (epiblast stem cells) differentiated to posterior primitive streak (PPS) in vitro, in a monolayer

Project description:EpiSCs established from murine epiblast were differentiated to posterior primitive streak (PPS) and analyzed using scRNA-seq to investigate identity and homogeneity of the resulting population.

2022-11-30 | E-MTAB-12106 | biostudies-arrayexpress

Transcriptome of ESCs, EpiSCs and reverted ES by MM401 (Mll1 inhibitor) #2

Project description:This study describes the transcriptome profiling of: 1) mouse ES cells in LIF/KSR medium; 2)EpiSCs in bFGF/serum-free (KSR) medium; 3) EpiSCs treated with MM401/LIF KSR at D3 and D6 (P2); 4) rES reverted form EpiSC by MM401/LIF KSR treatment at P6, P30 with or without MM401 .

2016-05-21 | GSE73993 | GEO

Genome-wide impact of substrate stiffness on embryonic stem cell pluripotency and the signalling pathways controlling it

Project description:GOAL: The goal of this study was to assess the impact of substrate stiffness on the gene expression of pluripotent embryonic stem cells, in different heterogeneous conditions. Embryonic stem cells cultured on tissue culture plastic have heterogeneous gene expression when cultured in serum+LIF. We investigated whether culturing cells on soft fibronectin-coated StemBond hydrogels has genome-wide effects and in particular improves the homogeneity of naive pluripotent gene expression. To assess the interplay with multiple signalling pathways, we used multiple pluripotent conditions or differentiating conditions, by adding or removing the MEK inhibitor PD03, and the cytokine LIF.

2021-08-31 | GSE125614 | GEO

12h pathway stimulation / inhibition experiment in epiblast stem cells

Project description:This experiment records the transcriptional responses of EpiSCs (line E3) to FGF/ERK inhibition, GSK3ß inhibition, LIF/STAT3 activation, as well as combined treatment for 12 hours each.

2010-02-21 | GSE17134 | GEO

3h pathway stimulation / inhibition experiment in epiblast stem cells

2010-02-21 | GSE17133 | GEO

A novel mouse stem cell established in combination of Activin A and LIF

Project description:We reported the ALSCs derivation from E3.5 blastocysts and E6.5 epiblasts cultured in basic N2B27 medium supplemented with Acitivin A and LIF. Activin A subtitutes NODAL signaling in vivo and is an important factor for self-renewal. LIF is extracted from feeder and have an impact on sustaining pluripotency of ESCs. We combined the two factors and finding AL medium could sustaining a novel mouse embryonic stem cells. Furthermore, EpiSCs are also discovered that able to convert to rESCs by culturing in AL medium for several passages, which illustrates that AL medium not only support establishment of pluripotent stem cells from embryos in vivo but also could convert EpiSCs to rESCs. Then, based on multiple analyses of pluripotency, we performed RNA-seq of ALSCs to exploring the differences of ALSCs compared to EpiSCs and ESCs respctively. RNA-seq data showed ALSCs is different with EpiSCs or ESCs. Teratoma test proved ALSCs could contribute to three germ layers in vivo and embryonic body analysis testify ALSCs could differentiate to three germ layers like cells in vitro.

2021-07-06 | GSE156673 | GEO

Transcriptome of ESCs, EpiSCs and reverted ES by MM401 (Mll1 inhibitor)

Project description:This study describes the transcriptome profiling of: 1) mouse ES cells and EpiSCs in LIF/serum-free (KSR) medium; 2) E14Tg2a (E14) ES cells in LIF/Serum with or without MM401 treatment; 3) rES reverted form EpiSC by MM401/LIF KSR treatment at P6, P30. RNA-Seq profiling on mouse pluripotent cells. Biological duplicates of each sample are labled as rep1/2.

2016-02-19 | E-GEOD-66110 | biostudies-arrayexpress

RNA-seq of human ES cell lines HUES4 and H1, differentiated for 5 or 7 days towards pancreatic endoderm

Project description:The experiment was designed to unravel how endogenous signaling in differentiating hESCs is affected by exogenous factors. RNA-seq of human ES cell lines HUES4 and H1, differentiated for 5 or 7 days towards pancreatic endoderm. The cells were treated with IWP-L6, TGFb1 or both from day 3 and onwards. Vehicle controls were done with 0.1% DMSO.

2022-06-18 | E-MTAB-10715 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data